SEC Form 4 · accession 0001179110-19-002128
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Hugin
Director
Period of report
Feb 18, 2019
Accepted (ET)
Feb 20, 2019 · 11:26 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2 | Feb 18, 2019 | A | 426 | $139.07 | A | 3,426 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units shall vest on the earlier of (i) the day before the 2019 Annual General Meeting of Shareholders and (ii) May 2, 2019.
- F2Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc.